TUCSON, AZ--(Marketwire - December 03, 2007) - CDEX, Inc. (OTCBB: CEXI) announces that effective November 27, 2007, it has taken steps to strengthen its Corporate structure by amending its Bylaws and realigning its Board of Director Committees. “With the growing number of ValiMed™ hospital clients and commercialization of our Methamphetamine Scanner, we are receiving increasing national and international visibility and inquiries regarding our company,” said Malcolm Philips, CEO and Chairman of the Board of CDEX, Inc. “In the face of this increasing exposure, the Board instituted Bylaw changes to strengthen the corporate structure. In addition, taking advantage of the expanding expertise on our Board, we have restructured Committee assignments and adopted new Committee Charters for our Audit, Compensation and Corporate Governance Committees. These steps will result in a more structured Board oversight of CDEX company actions, providing greater protection for our shareholders.” The amendments to the Bylaw are detailed in the required SEC 8K filed on December 2, 2007.
